Korro Bio, Inc.
KRRO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001703647
In the last 90 days, Korro Bio, Inc. insiders filed 1 open-market purchase and 8 sales; 106 institutions reported holding it in 13F filings for Q2 2026, worth $190.1M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Korro Bio, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 71 | 92 | +21 |
| Shares | 9.05M | 9.76M | +712.6K (+7.9%) |
| Value | $114.8M | $465.5M | +$350.7M (+305.5%) |
New holders (26)
Institutions that held Korro Bio, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
Sold out (5)
Institutions that held Korro Bio, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Deep Track Capital, LP | 277,966 | $3.47M |
| Ally Bridge Group (NY) LLC | 154,223 | $1.93M |
| D. E. Shaw & Co., Inc. | 24,383 | $304.5K |
| Walleye Capital LLC | 16,060 | $200.6K |
| Rise Advisors, LLC | 29 | $362 |